Gregory Glenn

Track

Insider profile

Currently holds a position at Novavax Inc

Performance

Overall performance
2.9
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
9 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 6%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
President, Research and Development Novavax Inc March 1, 2016 -
Senior Vice President - Research & Development Novavax Inc Jan. 13, 2014 - March 1, 2016
Senior Vice President, Chief Medical Officer Novavax Inc Jan. 1, 2011 - Jan. 13, 2014
Gregory Glenn's trades of Novavax Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-14 2023-03-10
US Novavax Inc (NVAX)
B Purchase
60,576 +48.5%
106.81
US$3,083,580 		60,576 +48.5% 106.81 US$3,083,580
2023-03-14 2023-03-07
US Novavax Inc (NVAX)
B Purchase
18,469 -45.3%
461.70
US$3,287,149 		18,469 -45.3% 461.70 US$3,287,149
2023-03-14 2023-03-06
US Novavax Inc (NVAX)
PP Planned purchase
25,819 +44.0%
276.81
US$644,658 		25,819 +44.0% 276.81 US$644,658
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
27 -0.5%
180.62
US$4,877 		27 -0.5% 180.62 US$4,877
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
206 -3.5%
179.58
US$36,993 		206 -3.5% 179.58 US$36,993
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
103 -1.7%
178.99
US$18,436 		103 -1.7% 178.99 US$18,436
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
223 -3.6%
176.83
US$39,432 		223 -3.6% 176.83 US$39,432
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
67 -1.1%
175.89
US$11,785 		67 -1.1% 175.89 US$11,785
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
137 -2.1%
174.65
US$23,927 		137 -2.1% 174.65 US$23,927
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
91 -1.4%
173.29
US$15,770 		91 -1.4% 173.29 US$15,770
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
248 -3.7%
172.38
US$42,750 		248 -3.7% 172.38 US$42,750
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
254 -3.6%
171.47
US$43,553 		254 -3.6% 171.47 US$43,553
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
213 -2.9%
170.46
US$36,309 		213 -2.9% 170.46 US$36,309
2021-12-16 2021-12-15
US Novavax Inc (NVAX)
PlS Planned sale
117 -1.6%
168.82
US$19,752 		117 -1.6% 168.82 US$19,752
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
100 -2.4%
182.96
US$18,296 		100 -2.4% 182.96 US$18,296
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
853 -17.0%
182.30
US$155,498 		853 -17.0% 182.30 US$155,498
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
500 -9.1%
180.29
US$90,147 		500 -9.1% 180.29 US$90,147
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
500 -8.3%
179.36
US$89,680 		500 -8.3% 179.36 US$89,680
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
500 -7.7%
178.21
US$89,104 		500 -7.7% 178.21 US$89,104
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
800 -10.9%
176.20
US$140,956 		800 -10.9% 176.20 US$140,956
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
900 -11.0%
175.13
US$157,619 		900 -11.0% 175.13 US$157,619
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
200 -2.4%
173.14
US$34,627 		200 -2.4% 173.14 US$34,627
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
200 -2.3%
171.30
US$34,260 		200 -2.3% 171.30 US$34,260
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
400 -4.4%
168.77
US$67,508 		400 -4.4% 168.77 US$67,508
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -3.2%
167.06
US$50,118 		300 -3.2% 167.06 US$50,118
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -3.1%
165.80
US$49,739 		300 -3.1% 165.80 US$49,739
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -3.0%
164.77
US$49,430 		300 -3.0% 164.77 US$49,430
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
200 -2.0%
162.83
US$32,565 		200 -2.0% 162.83 US$32,565
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -2.9%
161.63
US$48,490 		300 -2.9% 161.63 US$48,490
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -2.8%
160.52
US$48,157 		300 -2.8% 160.52 US$48,157
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -2.7%
158.42
US$47,527 		300 -2.7% 158.42 US$47,527
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
200 -1.8%
157.02
US$31,404 		200 -1.8% 157.02 US$31,404
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
300 -2.6%
156.24
US$46,873 		300 -2.6% 156.24 US$46,873
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
100 -0.9%
154.38
US$15,438 		100 -0.9% 154.38 US$15,438
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
397 -3.3%
153.53
US$60,951 		397 -3.3% 153.53 US$60,951
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
100 -0.8%
151.85
US$15,185 		100 -0.8% 151.85 US$15,185
2021-12-09 2021-12-07
US Novavax Inc (NVAX)
PlS Planned sale
200 -1.6%
150.30
US$30,059 		200 -1.6% 150.30 US$30,059
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
100 -2.4%
211.75
US$21,175 		100 -2.4% 211.75 US$21,175
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
551 -11.7%
210.57
US$116,026 		551 -11.7% 210.57 US$116,026
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
879 -15.7%
209.81
US$184,419 		879 -15.7% 209.81 US$184,419
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
1,450 -20.6%
208.78
US$302,727 		1,450 -20.6% 208.78 US$302,727
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
353 -4.8%
207.19
US$73,139 		353 -4.8% 207.19 US$73,139
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
439 -5.6%
206.06
US$90,462 		439 -5.6% 206.06 US$90,462
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
465 -5.6%
203.79
US$94,764 		465 -5.6% 203.79 US$94,764
2021-12-02 2021-11-30
US Novavax Inc (NVAX)
PlS Planned sale
715 -7.9%
202.37
US$144,692 		715 -7.9% 202.37 US$144,692